Understanding the benefits of risk-based optimization on clinical trial supply planning

Within his 10 years in the industry, Amaury’s objective has been to revolutionise planning and systems to make clinical supply chain more efficient, more ethical, less wasteful and more patient-centric.

Cyrille Lefèvre has been working on the optimization of end-to-end clinical supplies with N-SIDE for more than 8 years. He has experience advising both large and small pharma for the forecasting and optimization of their clinical trials for all phases and through multiple therapeutic areas. Cyrille also has extensive experience training teams focusing on strategic planning and improving IRT resupply algorithms and the way they are used.